Information  X 
Enter a valid email address

Oxford Biomedica PLC Ord 1P (OXB)

Date Time Source Announcement
01 Nov 2021 10:08 am
RNS
Long Term Incentive Plan Option Grant
  10:02 am
RNS
Total Voting Rights
19 Oct 2021 7:00 am
RNS
Boehringer Ingelheim Exercises Option
01 Oct 2021 9:51 am
RNS
Total Voting Rights
29 Sep 2021 5:54 pm
RNS
Holding(s) in Company
  5:36 pm
RNS
Directors Dealings / Market Share Purchases
28 Sep 2021 4:48 pm
RNS
Holding(s) in Company
  10:01 am
RNS
Total Voting Rights
22 Sep 2021 7:38 am
RNS
Strategic investment by Serum Life Sciences
  7:00 am
RNS
Interim Results
01 Sep 2021 10:48 am
RNS
Total Voting Rights
  7:00 am
RNS
Notice of Interim Results
03 Aug 2021 2:20 pm
RNS
LTIP Option Grant
02 Aug 2021 11:16 am
RNS
Total Voting Rights
15 Jul 2021 7:00 am
RNS
Non-Executive Director Appointment
06 Jul 2021 3:10 pm
RNS
Director/PDMR Shareholding
01 Jul 2021 11:35 am
RNS
Block listing Return
  10:43 am
RNS
Total Voting Rights
24 Jun 2021 1:05 pm
RNS
Directors Dealings / Market Share Purchases
09 Jun 2021 10:36 am
RNS
Holding(s) in Company
08 Jun 2021 2:32 pm
RNS
Grant of options
01 Jun 2021 10:13 am
RNS
Total Voting Rights
28 May 2021 7:00 am
EQS
Oxford Biomedica (OXB): Driving innovation in a thriving CGT industry
  7:00 am
RNS
Block Listing Application
  7:00 am
RNS
Result of AGM
27 May 2021 7:00 am
RNS
Board Change
25 May 2021 9:21 am
RNS
Director/PDMR Shareholding
21 May 2021 12:46 pm
RNS
PDMR Dealing
20 May 2021 11:42 am
RNS
PDMR Dealings
18 May 2021 7:00 am
RNS
Oxford Biomedica upgrades financial guidance
  7:00 am
GNW
Oxford Biomedica upgrades financial guidance for supply agreement with AstraZeneca for manufacture of COVID-19 Vaccine
10 May 2021 10:54 am
RNS
Holding(s) in Company
04 May 2021 10:29 am
RNS
Total Voting Rights
  10:27 am
RNS
Holdings in Company
27 Apr 2021 2:40 pm
RNS
2020 Annual report and Accounts & AGM Notification
26 Apr 2021 12:32 pm
RNS
Holding(s) in Company
15 Apr 2021 7:00 am
RNS
Full year results
06 Apr 2021 7:00 am
RNS
OXB signs Agreement with Boehringer Ingelheim
01 Apr 2021 11:04 am
RNS
Total Voting Rights
30 Mar 2021 10:22 am
RNS
Holding(s) in Company
19 Mar 2021 7:01 am
RNS
Update on Sanofi Collaboration & License Agreement
15 Mar 2021 10:03 am
RNS
Notice of Preliminary Results
01 Mar 2021 9:36 am
RNS
Total Voting Rights
26 Feb 2021 10:46 am
RNS
PDMR Dealings / Market Share sale
05 Feb 2021 1:22 pm
RNS
Holdings in Company
03 Feb 2021 7:00 am
RNS
Board Changes
01 Feb 2021 9:47 am
RNS
Total Voting Rights
18 Jan 2021 4:34 pm
RNS
Prime Minister Boris Johnson formally opens Oxbox
04 Jan 2021 2:09 pm
RNS
Block Listing Return
  1:41 pm
RNS
Total Voting Rights
30 Dec 2020 9:03 am
RNS
OXB notes AZ vaccine has been authorised in the UK
01 Dec 2020 12:17 pm
RNS
Director Dealings
  9:02 am
RNS
Total Voting Rights
23 Nov 2020 8:47 am
RNS
OXB notes AZD1222 met primary efficacy endpoint
  7:00 am
RNS
Non-Executive Director Appointment
09 Nov 2020 7:00 am
RNS
OXB and PhoreMost enter gene therapy collaboration
02 Nov 2020 9:02 am
RNS
Total Voting Rights
30 Oct 2020 7:00 am
RNS
Axovant update on AXO-Lenti-PD and virtual R&D day
23 Oct 2020 10:27 am
RNS
Director Purchase
12 Oct 2020 5:38 pm
RNS
Holding(s) in Company

a d v e r t i s e m e n t